Bristol-Myers Squibb Acquisitions
Bristol-Myers Squibb has acquired 28 companies and its latest acquisition was 2seventy Bio, Inc. on Mar 2025
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
2seventy Bio, Inc.
Mar 2025
Source »$286M
2seventy Bio is a Massachusetts-based biotechnology company that researches and develops cellular therapies for the treatment of cancer.
RayzeBio, Inc.
Dec 2023
Source »$4.1B
RayzeBio is a California-based biopharmaceutical company that researches and develops radiopharmaceutical drugs for the treatment of cancer.
Karuna Therapeutics, Inc.
Dec 2023
Source »$14B
Karuna is a Massachusetts-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of mental illnesses.
Frequently Asked Questions about Bristol-Myers Squibb
What companies did Bristol-Myers Squibb acquire?
Companies acquired by Bristol-Myers Squibb include 2seventy Bio, RayzeBio and KarunaHow many acquisitions does Bristol-Myers Squibb have?
Bristol-Myers Squibb has acquired 28 companies including 2seventy Bio, RayzeBio and Karuna.
How many acquisitions did Bristol-Myers Squibb make in 2025?
In 2025 Bristol-Myers Squibb acquired 1 companies including 2seventy Bio.